BridgeMD
New treatment option for Hiv
Official title Increasing PrEP With Trans Women in the Deep South
ClinicalTrials.gov ID: NCT05689281
What this study is testing
- What it's testing
- The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is to compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to the delayed study arm.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Provision of signed and dated informed consent form
- Declaration of willingness to comply with all study procedures and availability during the study
- Age 18 years old or older
- Male sex designated at birth
- Identify as trans woman, woman or another gender identity not associated with being a man
You likely can't join if
- Confirmed HIV infection by rapid algorithm testing and/or laboratory testing (described above)
- Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity
- Concurrent or planned enrollment in a research study that provides PrEP
- Unwilling to attend quarterly follow-up visits, which will include survey participation
- Has any other condition which, based on the opinion of the investigator, would preclude provision of informed consent; make participation in the...
See the full eligibility criteria
- Provision of signed and dated informed consent form
- Declaration of willingness to comply with all study procedures and availability during the study
- Age 18 years old or older
- Male sex designated at birth
- Identify as trans woman, woman or another gender identity not associated with being a man
- Desire to use or re-start PrEP
- HIV uninfected
- Speaks English or Spanish
- Live in the New Orleans metropolitan statistical area (which includes 8 parishes)
- Confirmed HIV infection by rapid algorithm testing and/or laboratory testing (described above)
- Prior or current participation in the active arm of an HIV vaccine trial with evidence of vaccine-induced seropositivity
- Concurrent or planned enrollment in a research study that provides PrEP
- Unwilling to attend quarterly follow-up visits, which will include survey participation
- Has any other condition which, based on the opinion of the investigator, would preclude provision of informed consent; make participation in the project unsafe; complicate interpretation of outcome data; or otherwise...
The study team makes the final eligibility decision.
Where it's taking place
- New Orleans, Louisiana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Orleans, Louisiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.